<DOC>
	<DOCNO>NCT00370019</DOCNO>
	<brief_summary>This study determine whether give estrogen replacement therapy estradiol patch improve ovulation rate woman spontaneous premature ovarian failure . The ovary glands woman produce female hormone normally release egg month . In woman spontaneous premature ovarian failure , ovary stop work soon . Women disorder abnormally high level leuteinizing hormone ( LH ) blood , impede normal ovulation . In woman , estrogen replacement suppress LH level normal range . Women 18 40 year age premature ovarian failure may eligible 4-month study . Participants receive either standard hormone replacement therapy , consist estradiol patch progestin tablet , placebo . The placebo group receive patch tablet look group active treatment contain hormone . All participant wear patch every day take tablet first 12 day month . In addition take study drug , participant blood drawn week 16 week study . At end trial , woman placebo group offer opportunity receive estrogen patch progestin therapy another 16 week continue blood test determine ovulate treatment .</brief_summary>
	<brief_title>Effects Estrogen Replacement Therapy Skin Patch Ovulation Women With Premature Ovarian Failure</brief_title>
	<detailed_description>Premature ovarian failure ( POF ) life alter distress diagnosis woman due associate infertility . Despite amenorrhea markedly elevate serum gonadotropin level , approximately 50 % woman 46XX spontaneous premature ovarian failure ovarian follicle function intermittently . These follicle face high serum LH level . Normally , woman LH level range 3-14 u/L except preovulatory stage , rise 20 u/L . At level work LH receptor granulosa cell transforms follicle corpus leutium . In POF , continuous high level LH prematurely lutienizes grow follicle thereby cause follicle dysfunction . We show histological examination inappropriate luteinization major mechanism Graffian follicle dysfunction woman . We find approximately 50 % woman premature ovarian failure LH level normal range take 100 mcg per day standardize transdermal estradiol therapy .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Menopause , Premature</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients karyotypically normal spontaneous premature ovarian failure ( define screen protocol 91CH0127 ) , i.e . woman least 4 month amenorrhea , two FSH level 40 mIU/mL , menopausal range , least one month apart , normal 46 , XX karyotype , diagnosed premature ovarian failure prior age 40 age 18 40 year candidate . Patients screen protocol 91CH0127 ( Ovarian follicle function patient karyotypically normal spontaneous premature ovarian failure ) . EXCLUSION CRITERIA : 1 . General smoker ( great 2 cigarettes/d ) , alcohol user ( great 2 drinks/d ) , body mass index ( BMI , kg/m ( 2 ) great equal 30 less equal 19 , major dermatologic disorder , history skin sensitivity adhesive bandage , tape transdermal matrix patch 2 . Hysterectomy 3 . Medication use current and/or past use : diuretic , anticoagulant ( heparin , coumadin ) , glucocorticoid drug , gonadotropinreleasing hormone agonist antagonist therapy , chemotherapy , use therapy induce ovulation clomiphene citrate assist reproductive technology . ( At present proven way improve ovulation rate woman ) 4 . Medical history anorexia nervosa , hyperprolactinemia , Cushing 's syndrome , gastrectomy , osteogenesis imperfecta , mastocytosis , rheumatoid arthritis , long term parenteral nutrition , hemolytic anemia , hemochromatosis thalassemia , ankylose spondylitis , multiple myeloma , cancer , major illness 5 . Contraindications hormone replacement therapy thromboembolic event associate previous estrogen use history endometrial cancer hyperplasia history breast cancer hypertriglyceridemia ( fast triglyceride level great 250 mg/dL ) undiagnosed vaginal bleeding know sensitivity agent . Active liver disease 3 time elevation liver enzymes .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 12, 2011</verification_date>
	<keyword>Premature Ovarian Failure</keyword>
	<keyword>Ovulation</keyword>
	<keyword>Fertility</keyword>
	<keyword>Estrogen Replacement</keyword>
	<keyword>Follicle Function</keyword>
	<keyword>Premature Menopause</keyword>
	<keyword>POF</keyword>
</DOC>